Evidence map›Paper›PMID 36686671›Full record

ArticleFrontiers in pharmacology2022

Gender-specific association between the regular use of statins and the risk of irritable bowel syndrome: A population-based prospective cohort study.

Xiaoying Zhang, Yuyao Liu, Yanghui Ou, Man Yang, Jinqiu Yuan, Qiangsheng He, Yanfei Li, Ningning Mi, Peng Xie, Wenjing Li and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Xiaoying ZhangHealth Management Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Yuyao LiuSchool of Medicine, Sun Yat-sen University, Shenzhen, China.
Yanghui OuCenter for Digestive Disease, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Man YangCenter for Digestive Disease, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Jinqiu YuanCenter for Digestive Disease, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Qiangsheng HeClinical Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, , China.
Yanfei LiChinese Health Risk Management Collaboration (CHRIMAC), Shenzhen, China.
Ningning MiEvidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Peng XieCenter for Digestive Disease, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Wenjing LiClinical Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, , China.
Siqin WuSchool of Medicine, Sun Yat-sen University, Shenzhen, China.
Xiwen QinSpecial Minimally Invasive Surgery Department, The First Hospital of Lanzhou University, Lanzhou, China.
Jian QiCenter for Digestive Disease, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Bin XiaClinical Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, , China.
The Seventh Affiliated Hospital of Sun Yat-sen University · CNSun Yat-sen University · CNLanzhou University · CNUniversity of Western Australia · AU

Funding

Medical Research Council MC_PC_17228
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cohort study [or longitudinal study]irritable bowel syndromeprotective factorstatins (3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors)United Kingdom Biobank

Identifiers

PMID36686671
PMCPMC9853052
OpenAlexW4313650146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.